Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus

被引：9

作者：

Lee, J-W ^{[1
]}

Kim, H-A ^{[1
]}

Sung, J-M ^{[1
]}

Suh, C-H ^{[1
]}

机构：

[1] Ajou Univ, Dept Allergy & Rheumatol, Sch Med, Suwon 443721, South Korea

来源：

LUPUS | 2010年 / 19卷 / 02期

关键词：

RITUXIMAB TREATMENT;

D O I：

10.1177/0961203309345723

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：227 / 228

页数：2

共 6 条

[1] Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis [J].

Gunnarsson, Iva ;

Sundelin, Birgitta ;

Jonsdottir, Thorunn ;

Jacobson, Stefan H. ;

Henriksson, Elisabet Welin ;

van Vollenhoven, Ronald F. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1263-1272

[2] Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus. [J].

Lehembre, S ;

Macario-Barrel, A ;

Musette, P ;

Carvalho, P ;

Joly, P .

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2006, 133 (01) :53-55

[3]

Lindholm C, 2008, J RHEUMATOL, V35, P826

[4]

MestanzaPeralta M, 1997, J RHEUMATOL, V24, P867

[5] THE SIGNIFICANCE OF THROMBOCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

MILLER, MH ;

UROWITZ, MB ;

GLADMAN, DD .

ARTHRITIS AND RHEUMATISM, 1983, 26 (10) :1181-1186

[6]

Perrotta S, 2002, BRIT J HAEMATOL, V116, P465, DOI 10.1046/j.0007-1048.2001.03278.x

← 1 →